P
DGX icon

Pitcairn’s Quest Diagnostics DGX Stock Holding History

Pitcairn’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,342
Closed -$600K – 653
2025
Q2 		$600K Sell
3,342
-642
-16% -$112K 0.04% 368
2025
Q1 		$674K Buy
+3,984
New +$654K 0.04% 349
2023
Q3 		– Sell
-3,042
Closed -$428K – 654
2023
Q2 		$428K Sell
3,042
-1,184
-28% -$163K 0.04% 410
2023
Q1 		$598K Sell
4,226
-521
-11% -$74.5K 0.06% 299
2022
Q4 		$743K Sell
4,747
-2,281
-32% -$328K 0.07% 234
2022
Q3 		$862K Sell
7,028
-1,533
-18% -$202K 0.09% 201
2022
Q2 		$1.14M Buy
8,561
+2,477
+41% +$338K 0.12% 156
2022
Q1 		$833K Sell
6,084
-3,367
-36% -$469K 0.07% 233
2021
Q4 		$1.64M Buy
9,451
+4,529
+92% +$689K 0.11% 137
2021
Q3 		$716K Buy
4,922
+2,962
+151% +$433K 0.05% 260
2021
Q2 		$258K Buy
1,960
+86
+5% +$11.3K 0.02% 535
2021
Q1 		$241K Buy
1,874
+187
+11% +$23K 0.02% 542
2020
Q4 		$201K Buy
+1,687
New +$206K 0.02% 556
2015
Q2 		– Sell
-5,793
Closed -$445K – 477
2015
Q1 		$445K Sell
5,793
-31
-0.5% -$2.22K 0.05% 284
2014
Q4 		$391K Buy
5,824
+136
+2% +$8.58K 0.04% 311
2014
Q3 		$345K Sell
5,688
-108
-2% -$6.66K 0.04% 345
2014
Q2 		$340K Buy
+5,796
New +$339K 0.04% 341
2013
Q3 		– Sell
-3,476
Closed -$211K – 451
2013
Q2 		$211K Buy
+3,476
New +$207K 0.03% 402

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pitcairn's DGX Position: Q3 2025 in Review

Pitcairn sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 3,342 shares — an estimated $600K sold.

Pitcairn first reported a position in DGX in Q2 2013 and held it in 18 quarters. The position peaked at $1.64M in Q4 2021. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Pitcairn reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Pitcairn sold 3,342 Quest Diagnostics shares in Q3 2025, an estimated $600K.
  • Pitcairn first reported a position in Quest Diagnostics in Q2 2013 and held it in 18 quarters.
  • Pitcairn's Quest Diagnostics position peaked at $1.64M in Q4 2021.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Pitcairn's 13F filing for Q3 2025, filed 12 Nov 2025.